La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Hybio Pharmaceutical Bilan de santé
Santé financière contrôle des critères 1/6
Hybio Pharmaceutical has a total shareholder equity of CN¥774.2M and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 220.2%. Its total assets and total liabilities are CN¥3.0B and CN¥2.2B respectively.
Informations clés
220.2%
Ratio d'endettement
CN¥1.71b
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | CN¥45.30m |
| Fonds propres | CN¥774.25m |
| Total du passif | CN¥2.22b |
| Total des actifs | CN¥2.99b |
Mises à jour récentes de la santé financière
Here's Why Hybio Pharmaceutical (SZSE:300199) Can Afford Some Debt
Jul 20
Is Hybio Pharmaceutical (SZSE:300199) Using Too Much Debt?
Feb 26Recent updates
Here's Why Hybio Pharmaceutical (SZSE:300199) Can Afford Some Debt
Jul 20Hybio Pharmaceutical Co., Ltd.'s (SZSE:300199) Price Is Out Of Tune With Revenues
Jun 03Hybio Pharmaceutical Co., Ltd.'s (SZSE:300199) 27% Share Price Surge Not Quite Adding Up
Feb 29Is Hybio Pharmaceutical (SZSE:300199) Using Too Much Debt?
Feb 26Analyse de la situation financière
Passif à court terme: 300199's short term assets (CN¥421.1M) do not cover its short term liabilities (CN¥1.0B).
Passif à long terme: 300199's short term assets (CN¥421.1M) do not cover its long term liabilities (CN¥1.2B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 300199's net debt to equity ratio (214.4%) is considered high.
Réduire la dette: 300199's debt to equity ratio has increased from 57.7% to 220.2% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: 300199 has sufficient cash runway for more than a year based on its current free cash flow.
Prévisions de trésorerie: 300199 has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.5% each year.